Digital Is DTx finally reaching drug-like efficacy? A Q&A with David... Click Therapeutics CEO David Benshoof Klein shares thoughts on what's been holding DTx back and why this could be the moment for a breakout.
Digital Molecules, DTx, and a breakthrough in chronic cough Early evidence for a cough treatment digital therapeutic is compelling.
Digital Transforming Pharma: Insights from Frontiers Health 2025 pharmaphorum caught up with Emre Ozcan (Merck Group) after his onstage session at Frontiers Health.
Digital Ten years of innovation at Frontiers Health – Live from Berl... Tune into a wrap-up podcast from Frontiers Health 2025, with Jonah Comstock, Nicole Raleigh, and Jessica DaMassa.
News Boehringer, Click DTx for schizophrenia clears pivotal trial Boehringer Ingelheim and Click Therapeutics have revealed the data from their pivotal trial of a digital therapeutic for schizophrenia.
News Scoop: Lumos Labs has FDA nod for ADHD DTx Prismira Lumos Labs has secured its first 510(k) clearance for a digital therapeutics offering, paving the way for entrance into the regulated app market.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.